Logo image of INGN

INOGEN INC (INGN) Stock Fundamental Analysis

NASDAQ:INGN - Nasdaq - US45780L1044 - Common Stock - Currency: USD

8.715  -0.8 (-8.46%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to INGN. INGN was compared to 189 industry peers in the Health Care Equipment & Supplies industry. INGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. INGN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

INGN had negative earnings in the past year.
INGN had a positive operating cash flow in the past year.
In the past 5 years INGN always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: INGN reported negative operating cash flow in multiple years.
INGN Yearly Net Income VS EBIT VS OCF VS FCFINGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

The Return On Assets of INGN (-17.21%) is comparable to the rest of the industry.
INGN has a Return On Equity (-28.42%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -17.21%
ROE -28.42%
ROIC N/A
ROA(3y)-17.8%
ROA(5y)-9.99%
ROE(3y)-26.63%
ROE(5y)-15.09%
ROIC(3y)N/A
ROIC(5y)N/A
INGN Yearly ROA, ROE, ROICINGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40

1.3 Margins

INGN has a Gross Margin of 44.22%. This is in the lower half of the industry: INGN underperforms 63.64% of its industry peers.
INGN's Gross Margin has declined in the last couple of years.
INGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y-4.25%
INGN Yearly Profit, Operating, Gross MarginsINGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

INGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for INGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INGN Yearly Shares OutstandingINGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
INGN Yearly Total Debt VS Total AssetsINGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

INGN has an Altman-Z score of 1.41. This is a bad value and indicates that INGN is not financially healthy and even has some risk of bankruptcy.
INGN's Altman-Z score of 1.41 is in line compared to the rest of the industry. INGN outperforms 54.55% of its industry peers.
INGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.41
ROIC/WACCN/A
WACC9.04%
INGN Yearly LT Debt VS Equity VS FCFINGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.66 indicates that INGN has no problem at all paying its short term obligations.
INGN has a Current ratio (2.66) which is comparable to the rest of the industry.
INGN has a Quick Ratio of 2.34. This indicates that INGN is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of INGN (2.34) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 2.34
INGN Yearly Current Assets VS Current LiabilitesINGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.16% over the past year.
EPS 1Y (TTM)49.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.04%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.51%

3.2 Future

The Earnings Per Share is expected to grow by 2.22% on average over the next years.
Based on estimates for the next years, INGN will show a small growth in Revenue. The Revenue will grow by 5.08% on average per year.
EPS Next Y-0.66%
EPS Next 2Y2.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.55%
Revenue Next 2Y5.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

INGN Yearly Revenue VS EstimatesINGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
INGN Yearly EPS VS EstimatesINGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INGN Price Earnings VS Forward Price EarningsINGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INGN Per share dataINGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.22%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

INGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INOGEN INC

NASDAQ:INGN (2/26/2025, 12:47:31 PM)

8.715

-0.8 (-8.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners89.01%
Inst Owner Change-98.57%
Ins Owners1.54%
Ins Owner Change0.33%
Market Cap208.29M
Analysts51.11
Price Target10.2 (17.04%)
Short Float %3.41%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)53.66%
Min EPS beat(2)50.49%
Max EPS beat(2)56.83%
EPS beat(4)3
Avg EPS beat(4)12.07%
Min EPS beat(4)-78.82%
Max EPS beat(4)56.83%
EPS beat(8)5
Avg EPS beat(8)15.6%
EPS beat(12)7
Avg EPS beat(12)10.96%
EPS beat(16)11
Avg EPS beat(16)51.89%
Revenue beat(2)2
Avg Revenue beat(2)4.5%
Min Revenue beat(2)3.51%
Max Revenue beat(2)5.48%
Revenue beat(4)3
Avg Revenue beat(4)2.37%
Min Revenue beat(4)-3.35%
Max Revenue beat(4)5.48%
Revenue beat(8)3
Avg Revenue beat(8)-1.32%
Revenue beat(12)6
Avg Revenue beat(12)-0.21%
Revenue beat(16)10
Avg Revenue beat(16)1.71%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-4.06%
EPS NQ rev (3m)-4.06%
EPS NY rev (1m)0%
EPS NY rev (3m)8.89%
Revenue NQ rev (1m)-1.33%
Revenue NQ rev (3m)-1.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF N/A
P/OCF 35.99
P/B 1.12
P/tB 1.47
EV/EBITDA N/A
EPS(TTM)-1.52
EYN/A
EPS(NY)-1.53
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)0.24
OCFY2.78%
SpS13.87
BVpS7.76
TBVpS5.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.21%
ROE -28.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.22%
FCFM N/A
ROA(3y)-17.8%
ROA(5y)-9.99%
ROE(3y)-26.63%
ROE(5y)-15.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y-4.25%
F-Score6
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 96.15%
Cap/Sales 6.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.66
Quick Ratio 2.34
Altman-Z 1.41
F-Score6
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)116.78%
Cap/Depr(5y)93.93%
Cap/Sales(3y)6.97%
Cap/Sales(5y)5.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.04%
EPS Next Y-0.66%
EPS Next 2Y2.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.51%
Revenue Next Year4.55%
Revenue Next 2Y5.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.72%
EBIT Next 3Y24.43%
EBIT Next 5YN/A
FCF growth 1Y59.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y137.2%
OCF growth 3YN/A
OCF growth 5YN/A